Literature DB >> 19026771

Tubulopathy and pancytopaenia with normal pancreatic function: a variant of Pearson syndrome.

Agnès Atale1, Patrizia Bonneau-Amati, Agnès Rötig, Alain Fischer, Stéphanie Perez-Martin, Pascale de Lonlay, Patrick Niaudet, L De Parscau, C Mousson, C Thauvin-Robinet, A Munnich, F Huet, L Faivre.   

Abstract

Out of a series of 30 French patients with Pearson syndrome, we report on two patients with an atypical presentation, which include growth deficiency, pancytopaenia, tubulopathy and absence of exocrine pancreas dysfunction. Patient 1, a 4-year-old boy with a past history of pancytopaenia and transient metabolic acidosis at 13 months of age, presented at 2(1/2) years of age with severe tubulopathy of de Toni-Debré-Fanconi type, growth retardation, metabolic lactic acidosis and mild cytolysis. Despite normal exocrine pancreatic function, study of mitochondrial DNA revealed a 3.5 kb deletion. Patient 2 had a personal history of pancytopaenia requiring blood transfusions at 11 months of age and presented with severe intractable proximal and distal tubulopathy at 2 years of age. Exocrine pancreatic deficiency could not be evidenced and post-mortem studies revealed a 4.9 kb deletion of the mitochondrial DNA. A review of the literature revealed three patients presenting with Pearson syndrome and tubulopathy with normal pancreatic function and highlights delay in diagnosis in those three patients. The series of 30 French patients with Pearson syndrome also revealed that tubulopathy was present in 7/30 cases (23%), with variable outcome. In conclusion, Pearson syndrome should be screened for in children presenting with the association of growth retardation, anaemia/pancytopaenia, lactic acidosis and tubulopathy, even in the absence of exocrine pancreatic deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026771     DOI: 10.1016/j.ejmg.2008.10.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  7 in total

Review 1.  Pancreatic disease in children and adolescents.

Authors:  Christopher D Jolley
Journal:  Curr Gastroenterol Rep       Date:  2010-04

2.  Pearson Syndrome: A Retrospective Cohort Study from the Marrow Failure Study Group of A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica).

Authors:  Piero Farruggia; Andrea Di Cataldo; Rita M Pinto; Elena Palmisani; Alessandra Macaluso; Laura Lo Valvo; Maria E Cantarini; Assunta Tornesello; Paola Corti; Francesca Fioredda; Stefania Varotto; Baldo Martire; Isabella Moroni; Giuseppe Puccio; Giovanna Russo; Carlo Dufour; Marta Pillon
Journal:  JIMD Rep       Date:  2015-08-04

3.  Broadening the phenotypic spectrum of Pearson syndrome: Five new cases and a review of the literature.

Authors:  K Taylor Wild; Amy C Goldstein; Colleen Muraresku; Rebecca D Ganetzky
Journal:  Am J Med Genet A       Date:  2019-12-11       Impact factor: 2.802

Review 4.  Clinical manifestations and enzymatic activities of mitochondrial respiratory chain complexes in Pearson marrow-pancreas syndrome with 3-methylglutaconic aciduria: a case report and literature review.

Authors:  Takeshi Sato; Koji Muroya; Junko Hanakawa; Reiko Iwano; Yumi Asakura; Yukichi Tanaka; Kei Murayama; Akira Ohtake; Tomonobu Hasegawa; Masanori Adachi
Journal:  Eur J Pediatr       Date:  2015-06-16       Impact factor: 3.183

Review 5.  Mitochondrial DNA mutations in renal disease: an overview.

Authors:  Larissa P Govers; Hakan R Toka; Ali Hariri; Stephen B Walsh; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2020-01-10       Impact factor: 3.714

6.  Identification of a novel large deletion of the mitochondrial DNA in an infant with Pearson syndrome: a case report.

Authors:  Rui Liu; Gui-Ling Mo; Yuan-Zong Song
Journal:  Transl Pediatr       Date:  2021-01

7.  Clinical features of the pathogenic m.5540G>A mitochondrial transfer RNA tryptophan gene mutation.

Authors:  Yi Shiau Ng; Steven A Hardy; Venice Shrier; Gerardine Quaghebeur; David R Mole; Matthew J Daniels; Susan M Downes; Jane Freebody; Carl Fratter; Monika Hofer; Andrea H Nemeth; Joanna Poulton; Robert W Taylor
Journal:  Neuromuscul Disord       Date:  2016-08-17       Impact factor: 4.296

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.